Details for New Drug Application (NDA): 011047
✉ Email this page to a colleague
NDA 011047 describes CARDRASE, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional details are available on the CARDRASE profile page.
The generic ingredient in CARDRASE is ethoxzolamide. Additional details are available on the ethoxzolamide profile page.
The generic ingredient in CARDRASE is ethoxzolamide. Additional details are available on the ethoxzolamide profile page.
Summary for 011047
| Tradename: | CARDRASE |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | ethoxzolamide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011047
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 125MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 62.5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
